KEGG   DRUG: D04045Help
Entry
D04045                      Drug                                   
Name
Erlizumab (USAN/INN)
Activity
Adjunctive treatment to reperfusion therapy in acute myocardial infarction or other types of reperfusion therapy [monoclonal antibody]
Target
CD18 [HSA:4055] [KO:K03159];
CD11A (LFA-1) [HSA:3683] [KO:K05718]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules (CAMs)  
 
Brite
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  TNF receptor family
   LTBR (CD18) [HSA:4055] [KO:K03159]
    Erlizumab
     D04045  Erlizumab (USAN/INN)
 Others
  Cellular antigens
   CD11a [HSA:3683] [KO:K05718]
    Erlizumab
     D04045  Erlizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
211323-03-4
PubChem: 

» Japanese version   » Back
DBGET integrated database retrieval system